Join us for a webinar on April 29 from 3-4 pm PT / 6-7 pm ET with Solve Ramsay Research Grant winner Liisa K. Selin, MD, PhD (viral immunologist from the Univ. of Massachusetts Chan Medical School), Roshan Kumar, PhD (clinical stage global biotech company HiFiBiO Therapeutics), and the labs’ patient representatives Megan L. Fitzgerald, PhD, and Rivka Solomon, MS.
These two collaborating labs are studying dysregulated immune cells of ME/CFS and Long COVID patients. Their research goals include: gaining insights into the underlying immune mechanisms of these illnesses (including via antigen discovery); better understanding patient subgroups; and finding diagnostic biomarkers and therapeutic innovations.
The two labs received funding from the Patient Led Research Collaborative to collaborate on their current project analyzing T cells from ME/CFS and Long COVID patients both functionally and at a single-cell level.
Also at this webinar moderated by Solve CEO Emily Taylor, the Selin Lab will summarize their paper “Identification of CD8 T-cell dysfunction associated with symptoms in ME/CFS and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.”
Registration is free. Sign up here:
https://us02web.zoom.us/webinar/register/WN_mlr1fE3_RdKztSL3JIfSWQ
350 N Glendale Ave.
Suite B #368
Glendale, CA 91206
SolveCFS@SolveCFS.org
704-364-0016
EIN: 56-1683450
